Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11390868
APP PUB NO 20190024084A1
SERIAL NO

16145393

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to antisense oligonucleotides and/or compounds that modulate the expression of and/or function of Filaggrin (FLG), in particular, by targeting natural antisense polynucleotides of Filaggrin (FLG). The invention also relates to the identification of these antisense oligonucleotides and/or compounds and their use in treating diseases and disorders associated with the expression of FLG.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CURNA INC4400 BISCAYNE BOULEVARD MIAMI FL 33137

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Coito, Carlos West Palm Beach, US 38 392
Collard, Joseph Delray Beach, US 131 1373
Khorkova, Sherman Olga Tequesta, US 126 1039

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 19, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 19, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 19, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00